The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Upregulation of RAS pathway to predict the risk of distant metastases in HPV + oropharynx cancer.
 
Laura D. Locati
No Relationships to Disclose
 
Loris De Cecco
No Relationships to Disclose
 
Federica Perrone
No Relationships to Disclose
 
Barbara Cortelazzi
No Relationships to Disclose
 
Annunziata Gloghini
No Relationships to Disclose
 
Chiara Volpi
No Relationships to Disclose
 
Silvana Pilotti
No Relationships to Disclose
 
Roberta Granata
No Relationships to Disclose
 
Paolo Bossi
No Relationships to Disclose
 
Ester Orlandi
No Relationships to Disclose
 
Carlo Resteghini
No Relationships to Disclose
 
Salvatore Alfieri
No Relationships to Disclose
 
Cristiana Bergamini
No Relationships to Disclose
 
Maria Chiara Cau
No Relationships to Disclose
 
Martina Imbimbo
No Relationships to Disclose
 
Pasquale Quattrone
No Relationships to Disclose
 
Silvana Canevari
No Relationships to Disclose
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Debiopharm Group; Eisai; GlaxoSmithKline; Merck Serono; MSD; Novartis; SOBI; VentiRx
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Celgene; Debiopharm Group; Merck Serono; MSD; sobi